医药导报2025，Vol.44Issue(6)：906-911,6.DOI:10.3870/j.issn.1004-0781.2025.06.011
抑郁症与血清炎症因子的关系及其治疗研究进展
Research Progress on the Relationship Between Depression and Serum Inflammatory Factors and Their Treatment
摘要
Abstract
Depression is a chronic brain dysfunctional disease mainly due tomood disorders.Currently,the pathogenesis of depression is unclear,and its pathogenesis,pathophysiology and treatment have consistently been a major focus of academic research.This review provides an overview of the role of serum inflammatory factors in the pathogenesis,diagnosis,and treatment of depression.The inflammatory factor pathway provides a theoretical basis for the development of diagnostic and therapeutic methods for depression.It is expected to provide accurate personalized treatment for patients with depression through the treatment of inflammatory factors,improve the treatment outcomest,and reduce the risk of disease progression.关键词
抗抑郁药/生物活性化合物/抑郁症/血清炎症因子Key words
Antidepressants/Hydroxyeicosatetraenoic acids/Depression/Seruminflammatory factor分类
药学引用本文复制引用
杨淑,刘晓蕾,杨礼聪,张少川,鲍天昊,邰文琳..抑郁症与血清炎症因子的关系及其治疗研究进展[J].医药导报,2025,44(6):906-911,6.基金项目
国家自然科学基金资助项目(82160272) （82160272）
云南省科技厅科技计划项目(202001AT070314 （）
202405AC350104) （）
云南省科技厅-昆明医科大学应用基础研究联合专项(202401AY070001-313) （202401AY070001-313）
"春城计划"高层次人才培养计划春城拔尖人才专项(C201914016). （C201914016）
